Serial Clinical and Biomarker Monitoring During Graft-Versus-Host Disease Treatment Identifies Distinct Risk Strata Including an Ultra-Low Risk Group
Nikolaos Katsivelos,Nikolaos Spyrou,Daniela Weber,Ingrid Vasova,Francis Ayuk,Hannah Choe,William Hogan,Zachariah Defilipp,Muna Qayed,Aaron M. Etra, Karam Sandhu,Sabrina Kraus, Tim Olson,Elizabeth Hexner,Paibel Aguayo-Hiraldo,Ran Reshef,Evelyn Ullrich,Tal Schechter,Carrie Kitko,Chantiya Chanswangphuwana, Pietro Merli,Yu Akahoshi,Janna Baez,Gilbert Eng,Rahnuma Beheshti,Steven Kowalyk,George Morales, Ioannis Evangelos Louloudis,Rachel Young,Ernst Holler, Ryotaro Nakamura,James L. M. Ferrara,John E. Levine TRANSPLANTATION AND CELLULAR THERAPY（2025）
Key words
Acute GVHD,Biomarker,Treatment,Immunosuppression
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper